These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 1900005
1. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2. Kole KL, Gyetko MR, Simpson RU, Sitrin RG. Biochem Pharmacol; 1991 Feb 15; 41(4):585-91. PubMed ID: 1900005 [Abstract] [Full Text] [Related]
2. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester. Gyetko MR, Webb AC, Sitrin RG. J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763 [Abstract] [Full Text] [Related]
3. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. Gross TJ, Sitrin RG. J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845 [Abstract] [Full Text] [Related]
4. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Niedbala MJ, Stein-Picarella M. Blood; 1993 May 15; 81(10):2608-17. PubMed ID: 7683925 [Abstract] [Full Text] [Related]
5. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha. Gyetko MR, Shollenberger SB, Sitrin RG. J Leukoc Biol; 1992 Mar 15; 51(3):256-63. PubMed ID: 1311745 [Abstract] [Full Text] [Related]
6. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells. Rondeau E, Guidet B, Lacave R, Bens M, Sraer J, Nagamine Y, Ardaillou R, Sraer JD. Biochim Biophys Acta; 1990 Nov 12; 1055(2):165-72. PubMed ID: 2122915 [Abstract] [Full Text] [Related]
7. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells. Peraldi MN, Rondeau E, Medcalf RL, Hagège J, Lacave R, Delarue F, Schleuning WD, Sraer JD. Biochim Biophys Acta; 1992 Apr 07; 1134(3):189-96. PubMed ID: 1558843 [Abstract] [Full Text] [Related]
8. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Hagège J, Delarue F, Peraldi MN, Sraer JD, Rondeau E. Lab Invest; 1994 Dec 07; 71(6):828-37. PubMed ID: 7807964 [Abstract] [Full Text] [Related]
9. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor. Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R. J Cell Physiol; 1989 Jul 07; 140(1):119-30. PubMed ID: 2500450 [Abstract] [Full Text] [Related]
10. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways. Langer DJ, Kuo A, Kariko K, Ahuja M, Klugherz BD, Ivanics KM, Hoxie JA, Williams WV, Liang BT, Cines DB. Circ Res; 1993 Feb 07; 72(2):330-40. PubMed ID: 7678205 [Abstract] [Full Text] [Related]
11. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Schuster WA, Medcalf RL, Kruithof EK. Endocrinology; 1993 Oct 07; 133(4):1724-30. PubMed ID: 8404615 [Abstract] [Full Text] [Related]
12. Urokinase synthesis and binding by glomerular epithelial cells in culture. Rondeau E, Ochi S, Lacave R, He CJ, Medcalf R, Delarue F, Sraer JD. Kidney Int; 1989 Oct 07; 36(4):593-600. PubMed ID: 2554052 [Abstract] [Full Text] [Related]
13. Modulation of synovial fibroblast plasminogen activator and plasminogen activator inhibitor production by protein kinase C. Uhl J, Newton RC, Gross JL, Rommi W, Mochan E. Biochim Biophys Acta; 1991 Nov 21; 1097(4):283-8. PubMed ID: 1742333 [Abstract] [Full Text] [Related]
14. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. Genton C, Kruithof EK, Schleuning WD. J Cell Biol; 1987 Mar 21; 104(3):705-12. PubMed ID: 3102504 [Abstract] [Full Text] [Related]
15. Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937. Peiretti F, Fossat C, Anfosso F, Alessi MC, Henry M, Juhan-Vague I, Nalbone G. Blood; 1996 Jan 01; 87(1):162-73. PubMed ID: 8547638 [Abstract] [Full Text] [Related]
16. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA. Fukumoto S, Allan EH, Yee JA, Gelehrter TD, Martin TJ. J Cell Physiol; 1992 Aug 01; 152(2):346-55. PubMed ID: 1322417 [Abstract] [Full Text] [Related]
17. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells. Jakowlew SB, Mariano JM, You L. Growth Factors; 1997 Aug 01; 14(2-3):177-97. PubMed ID: 9255608 [Abstract] [Full Text] [Related]
18. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells. Song CY, Kim BC, Hong HK, Kim BK, Kim YS, Lee HS. Am J Physiol Renal Physiol; 2002 Sep 01; 283(3):F423-30. PubMed ID: 12167592 [Abstract] [Full Text] [Related]
19. jun-N-terminal kinase regulates thrombin-induced PAI-1 gene expression in proximal tubular epithelial cells. Pontrelli P, Ranieri E, Ursi M, Ghosh-Choudhury G, Gesualdo L, Paolo Schena F, Grandaliano G. Kidney Int; 2004 Jun 01; 65(6):2249-61. PubMed ID: 15149338 [Abstract] [Full Text] [Related]